| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |